First Time Loading...

Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 93.37 USD -1.92% Market Closed
Updated: May 8, 2024

Haemonetics Corp
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Haemonetics Corp
Net Income (Common) Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Net Income (Common)
$126.5m
CAGR 3-Years
5%
CAGR 5-Years
22%
CAGR 10-Years
13%
Cooper Companies Inc
NYSE:COO
Net Income (Common)
$290.8m
CAGR 3-Years
-49%
CAGR 5-Years
-4%
CAGR 10-Years
0%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Net Income (Common)
-$95m
CAGR 3-Years
N/A
CAGR 5-Years
38%
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Net Income (Common)
$462.2m
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
13%
Lantheus Holdings Inc
NASDAQ:LNTH
Net Income (Common)
$460.5m
CAGR 3-Years
N/A
CAGR 5-Years
61%
CAGR 10-Years
N/A

See Also

What is Haemonetics Corp's Net Income (Common)?
Net Income (Common)
126.5m USD

Based on the financial report for Dec 30, 2023, Haemonetics Corp's Net Income (Common) amounts to 126.5m USD.

What is Haemonetics Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
13%

Over the last year, the Net Income (Common) growth was 32%. The average annual Net Income (Common) growth rates for Haemonetics Corp have been 5% over the past three years , 22% over the past five years , and 13% over the past ten years .